Matthew Cassell has Hematology/oncology as his primary medical specialty. Their primary office is: 1704 23rd Ave in Meridian, Mississippi.
They're a part of the: Meridian Oncology Associates Pllc medical group which has around 4 members. You can call their office at 601-482-1555 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Mississippi School Of Medicine and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Matthew Cassell
Meridian Oncology Associates Pllc
1704 23rd Ave
Meridian, Mississippi 39301
601-482-1555
Phone: 601-482-1555
Enter a starting address:
Medical School: University Of Mississippi School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Matthew Cassell is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 0749446128
NPI #: 1427269331
NPI Created On: 05/24/2007
NPI Last Updated Listed as: 10/22/2020
Primary Taxonomy Code: 174400000X
License Number:
20329
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $100
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225301
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225303
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Payments Total: $8
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225305
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225307
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225309
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225311
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225313
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788225315
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781008649
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781008653
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
1704 23rd Ave
Meridian, MS
Meridian Oncology Associates Pllc
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Hematology/oncology
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Hematology/oncology
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Medical Oncology
1704 23rd Ave
Meridian Ms 39301-3103
Meridian Oncology Associates Pllc
Medical Oncology
View all 4 members of Meridian Oncology Associates Pllc medical group